Pipeline Progress - BINHUI BIOPHARM

Pipeline

Process

Candidates

Indication

Pre-clinical

IND

Doses Escalation (Phase I)

Doses Extension (Phase II)

Protal Study
(Phase III)

BS001(OH2 injection monotherapy)

Melanoma

mCRC

Esophagus cancer

Gastric cancer

(NSCLC)

Intra he patic cholangiocarcinoma
( IcC)

(HNC)

Liver cancer

Pancreatic Cancer

GBM

BS001 combo with
PD-1

Melanoma

Liver cancer

Gastrointestinal tumors

BS001 combo with
PD-L1

Gastrointestinal tumors

Research

Center

Nansha Islands

Introduction to Clinical Centers

The clinical trials of oncolytic type II herpes simplex virus OH2 injection (BS001) monotherapy/combination therapy have been conducted in 20+ research centers (hospitals) in China, Nearly 300 subjects were enrolled for various indications.